Form 8-K - Current report:
SEC Accession No. 0000950170-25-012021
Filing Date
2025-02-03
Accepted
2025-02-03 07:30:08
Documents
13
Period of Report
2025-02-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20250203.htm   iXBRL 8-K 42015
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 23789
3 GRAPHIC img90053791_0.jpg GRAPHIC 9559
  Complete submission text file 0000950170-25-012021.txt   198857

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250203.xsd EX-101.SCH 24849
15 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250203_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 25580618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)